Rational prescribing for postmenopausal urogenital complaints

Area of Science:

• Gynecology
• Urology
• Geriatrics

Background:

• Over 50% of postmenopausal women experience urogenital complaints, significantly reducing quality of life and increasing healthcare costs.
• Symptoms include vaginal discomfort, dysuria, dyspareunia, recurrent urinary tract infections (UTIs), and urinary incontinence.
• The prevalence of these issues is projected to rise with an aging global population.

Purpose of the Study:

• To evaluate the efficacy of low-potency estrogen therapy in managing urogenital symptoms in postmenopausal women.
• To assess the impact of estrogen therapy on vaginal flora and UTI risk.
• To review the role of antibiotics versus estrogens in treating these conditions.

Main Methods:

• Review of existing literature on estrogen therapy for postmenopausal urogenital symptoms.
• Analysis of studies investigating the effects of topical and oral low-potency estrogens.
• Comparison of estrogen therapy outcomes with antibiotic use for specific urogenital complaints.

Main Results:

• Low-potency estrogens, administered orally or topically, effectively alleviate symptoms like urgency, urge incontinence, frequency, nocturia, and dysuria.
• Estrogen therapy improves urogenital atrophy and positively alters vaginal bacterial flora, reducing UTI risk.
• Evidence supporting antibiotics for local urogenital complaints (pruritus, discharge) or incontinence is limited; antibiotics are primarily indicated for UTIs.

Conclusions:

• Low-potency estrogen therapy is a well-established, effective treatment for a range of urogenital symptoms in postmenopausal women.
• Estrogen therapy offers a safe and effective alternative to antibiotics for managing many urogenital issues, particularly those related to atrophy.
• Given the increasing elderly population, topical or oral low-potency estrogens represent a crucial therapeutic option for improving women's health and well-being.